Inovio Pharmaceuticals Inc

NASDAQ:INO   3:59:57 PM EDT
7.39
-0.38 (-4.89%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.55B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.87 Million
Adjusted EPS-$0.32
See more estimates
10-Day MA$7.80
50-Day MA$8.39
200-Day MA$9.17
See more pivots

Inovio Pharmaceuticals Inc Stock, NASDAQ:INO

660 West Germantown Pike, Suite 110, Plymouth Meeting, Pennsylvania 19462-1111
Phone: +1.267.440.4200
Number of Employees: 262

Description

Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its product pipeline include VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.